Pharmafile Logo
Pharmafocus logo
Advanced Search

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma

October 30, 2024
Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors

Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …

News

Darrin Schellin appointed new CEO at Pharma Tech Industries

October 30, 2024
CEO, Pharma Tech Industries, manufacturing and packaging, pharmaceutical

Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment …

Appointment

HIV vaccine candidate successfully optimised for industrial production

October 30, 2024
Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …

News
cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024
Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …

News

From molecule to market and beyond: Uniphar announces extended global commercialization platform

October 25, 2024
CRO, UniPhar, cell and gene

22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …

News
Press release

Shawn Cross appointed as chief financial officer for Pacira Biosciences

October 25, 2024
Research and Development Pacira Biosciences

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …

Appointment

VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases

October 25, 2024
Nephrology, Rare Diseases, rare kidney disease, trial

SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit …

News

Stelis, Strides and Steriscience merge to form new CDMO

October 22, 2024
Research and Development CMDO, CPhI, Corporate, bangalore, merger

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …

News

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

October 21, 2024
Research and Development CHMP, EMA, EU, Internal Medicine, gene

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …

News

Eli Lilly appoints new chief AI officer

October 17, 2024
AI and ML, Corporate, Eli Lilly

Eli Lilly has announced the appointment of Thomas J Fuchs as its first chief artificial intelligence (AI) officer. Fuchs’ appointment …

Appointment

FlyPharma Europe, Vienna – 23-24 October 2024 conference

October 14, 2024
Conference, Corporate, flypharma, pharmaceutical

Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return to Office Park 4, Vienna …

News
Press release

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024
Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …

News
Press release
handshake

Strategic alliance announced between Recipharm and Exela

October 1, 2024
Research and Development Corporate, Exela, Recipharm, US

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …

News

Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone

October 1, 2024
Research and Development Cardiology, Duchenne Muscular Dystrophy, Immunology, Santhera Pharmaceuticals, clinical studies

Santhera Pharma has announced the results of its LIONHEART study, which evaluated vamorolone – a corticosteroid – and confirmed its …

News

Prilenia appoints new management staff to advance company’s development and commercialisation plans

September 30, 2024
Corporate, prilenia

Prilenia, a clinical stage biotech focusing on neurodegenerative and neurodevelopmental disorders, has announced the appointment of two new senior staff …

Appointment

Vertex Highlights First Oral Presentation of Phase 3 Clinical Dataof the Vanzacaftor Triple Combination and New Data on Long-Term Impact of TRIKAFTA at the North American CysticFibrosis Conference

September 30, 2024
Vertex Pharma

Phase 3 data on investigational vanzacaftor triple combination demonstrates noninferiorityto TRIKAFTA® in ppFEV1 and further improvement of CFTR functionas measured …

News
Press release

Eli Lilly announces two senior hires in Public Affairs and Communications team

September 27, 2024
Corporate, Eli Lilly

Pharmaceutical company Eli Lilly has announced the appointment of two senior positions in its Public Affairs and Communications team. James …

Appointment

Laurence Reid and Brad Crutchfield appointed to Broken Strings’ board of directors

September 25, 2024
Broken String Biosciences, Corporate

Cambridge, UK-based genomics company Broken String Biosciences has announced the appointment of Laurence Reid PhD as chairman, and Brad Crutchfield …

Appointment

Third application for Orion’s prostate cancer drug submitted by partner Bayer

September 23, 2024
Bayer, Cancer, Oncology, orion, prostate cancer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application of its prostate cancer drug, …

News

Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin

September 19, 2024
Business Services, Research and Development AI, Corporate, LabTwin, laboratory

The two Berlin-based companies labforward and LabTwin, a subsidiary of the life science group Sartorius, are merging in order to …

News
Press release
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026